It has also been described that ketoconazole at 10 and 20 μM strongly enhanced cell growth inhibition and apoptosis of paclitaxel or cisplatin in ovarian cancer cells through its pregnane X receptor (PXR) antagonism. Here, NR1I2 is linked to ovarian carcinoma.